Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 2 Mar 23 424B5 Prospectus supplement for primary offering
- 20 May 22 424B5 Prospectus supplement for primary offering
- 6 May 22 424B5 Prospectus supplement for primary offering
- 5 May 22 FWP Free writing prospectus
- 9 Feb 22 424B5 Prospectus supplement for primary offering
- 15 Jul 20 EFFECT Notice of effectiveness
-
6 Jul 20 S-3 Shelf registration
SYRE similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of Aeglea BioTherapeutics, Inc. of our report dated February 24, 2020 relating to the financial statements, which appears in Aeglea BioTherapeutics, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2019. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
| /s/ PricewaterhouseCoopers LLP |
| Austin, Texas |
| July 6, 2020 |